News from rxi pharmaceuticals corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 27, 2015, 09:02 ET

RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer

 RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive...

Mar 23, 2015, 07:02 ET

RXi Pharmaceuticals Reports Positive Advancements in its Dermatology Programs at the Occasion of the 73rd Annual Meeting of the American Academy of Dermatology

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing...

Mar 16, 2015, 07:02 ET

RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2014 Financial Results on Monday, March 30, 2015

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics...

Mar 11, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 73rd Annual Meeting of the American Academy of Dermatology

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, that...

Feb 05, 2015, 07:02 ET

RXi Pharmaceuticals Announces Closing of the Exclusive Global Licensing Agreement to Samcyprone™ with Hapten Pharmaceuticals

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing...

Feb 03, 2015, 07:02 ET

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Feb 02, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Jan 05, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 7th Annual Biotech Showcase™

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Dec 22, 2014, 07:02 ET

RXi Pharmaceuticals Issues Open Letter to Shareholders

MARLBOROUGH, Mass, Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on...

Dec 19, 2014, 07:05 ET

RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Dec 17, 2014, 07:02 ET

RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Nov 13, 2014, 07:10 ET

RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2014

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Oct 07, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present New Data in its First Phase 2a Clinical Trial with RXI-109

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Sep 29, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the 13th Annual BIO Investor Forum

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Sep 18, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Sep 17, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Sep 11, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Presented an Update on the Company's Dermatology and Ophthalmology Franchises

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Sep 03, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Aug 14, 2014, 07:05 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...

Aug 04, 2014, 07:02 ET
RXi Pharmaceuticals.  (PRNewsFoto/RXi Pharmaceuticals Corporation)

RXi Pharmaceuticals to Ring the NASDAQ Stock Market Closing Bell

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...